Sarasota, FL -- (SBWire) -- 06/15/2018 --Global Ovarian Cancer Market: Overview

Ovarian Cancer refers to cancerous growth which affects the ovaries. Risk factors causing ovarian cancer are family history, age, reproductive history, birth control, and hormonal therapy. Signs and symptoms of the ovarian cancer include nausea, indigestion, heaviness in the pelvis, discomfort and pain in the lower abdomen, irregularities in menstruation and back pain. Treatment of ovarian cancer depends upon the stage including drug therapy, surgeries, chemotherapy and radiotherapy. Another major factor bolstering the ovarian cancer market demand owing to increasing number of therapies and diagnostics for ovarian cancer.

Request Free Research Report Brochure @ https://bit.ly/2l8KQtj

Global Ovarian Cancer Market: Growth Factors

Increasing incidence of ovarian cancer, raising awareness about one's health, need for effective treatment, increasing population of elderly women, improved healthcare facilities and government initiatives, growing understanding of cancer and tumors are some of the market factors driving the global ovarian cancer market over the forecast period. Drugs such as Avastin and Votrint can boost the growth of the market across the globe. Lack of early-stage detection, patent expiration of drugs such as Taxol and launch of generic drugs are anticipated to restraint the global ovarian cancer market. Research and development of new drugs and diversification is an opportunity whereas lack of accuracy in diagnosis, improving efficacy of drugs is a major challenge for the global ovarian cancer market.

Global Ovarian Cancer Market: Segmentation

The ovarian cancer market can be classified in terms of stages of cancer, types of cancer, diagnosis, type of drugs, type of treatment and Region. In terms of stages of cancer, the market is categorized into Stage I - IA, IB, IC; Stage II - IIA, IIB; Stage III - IIIA1, IIIA2, IIIB, IIIC; Stage IV - IVA, IVB. Based on types of cancer the global ovarian cancer market is classified into epithelial ovarian tumors ( arise from cells that cover the ovary's outer surface)., germ cell tumors (originate at the cells producing ova), stromal tumors ( developing from the connective tissue cells, those producing hormones like estrogen), and peritoneal tumors (develops on the peritoneal layer). Based on diagnosis, the global market for ovarian cancer has been segmented into PET, CT scans; MRI, Ultrasound, Biopsy, HCG test, Physical examination, Blood tests. Based on type of drugs: Avastin, Carboplatin, Cisplatin, Cyclophosphamide, Gemcitabine Hydrochloride. Based on type of treatment the global ovarian cancer market is classified into targeted therapy, chemotherapy, radiation therapy, surgery, and immunotherapy. Based on end user the global ovarian cancer market is classified into cancer research institutes, hospital and hospital-associated labs, independent diagnostic laboratories, and ambulatory surgical centers.

Request Free Sample Report @ https://bit.ly/2HR13Mv

Global Ovarian Cancer Market: Regional Analysis

U. S. ovarian cancer market is expected to account for lion's share in the North America, attributed to presence of advanced medical technologies. Moreover, North America ovarian cancer has the dominant share in global market owing to the increasing number of elderly population. Europe is the second largest in terms of this market as there are rising number of incidences of ovarian cancer in this region. The Asia Pacific is expected to show significant growth in the ovarian cancer market. The countries like India and China are expected to expand at a rapid growth rate in the Asia Pacific region owing to a substantial increase in the healthcare infrastructure. In the Middle East and Africa, awareness about different types of cancer, their diagnosis, and available treatment options is anticipated to enhance the market growth. Germany and France are the largest contributors to the market growth owing to increasing investments in cancer research.

Global Ovarian Cancer Market: Competitive Players

Some of the most important market players in the global ovarian cancer market are F. Hoffmann-La Roche Ltd, Pfizer Inc., Adgero Biopharmaceuticals Inc, GlaxoSmithKline plc, Genentech Inc. , Boehringer Ingelheim GmbH, Bristol Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Cellceutix Corporation, Eli Lilly and Company, Johnson & Johnson Services, Novogen Limited, Aeterna Zentaris Inc, Chemo Espana SL, and Takeda Pharmaceutical Company Limited.

Inquiry more about this report @ https://bit.ly/2yd7z0z

Global Ovarian Cancer Market: Regional Segment Analysis

North America
The U.S.
Europe
The UK
France
Germany
The Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa

Browse detail report @ https://bit.ly/2HOymjB

About Zion Market Research
Zion Market Research is an obligated company. We create futuristically, cutting edge, informative reports ranging from industry reports, a company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with Vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from Cardinal Industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.